MDA-7– synthetic, strong CB2 agonist

 

MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.         (full – 2008)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597252/

 

Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.                                                                                    (abst – 2012)  http://www.ncbi.nlm.nih.gov/pubmed/22392969

 

Cannabinoid Receptor Stimulator Reverses Symptoms of Alzheimer’s Disease in Animal Model  (news – 2012)                               http://www.biotechdaily.com/?option=com_article&Itemid=294742494

 

Researchers investigating potential drug for treatement of Alzheimer’s disease (news – 2012)

http://medicalxpress.com/news/2012-08-potential-drug-treatement-alzheimer-disease.html

 

Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. (abst – 2013)                                            http://www.ncbi.nlm.nih.gov/pubmed/22795792

 

In vivo efficacy of enabling formulations based on hydroxypropyl-β-cyclodextrins, micellar preparation, and liposomes for the lipophilic cannabinoid CB2 agonist, MDA7. 

(abst – 2013)                      http://www.ncbi.nlm.nih.gov/pubmed/23192786

Share a link for